An analyst's downbeat new take on Summit Therapeutics (SMMT -3.28%) pushed its stock downward on Hump Day. At the end of Wednesday, the shares had booked a loss of over 11% in price as investors ...

Partnership aims to develop first-in-class, small molecule therapeutics directed at a novel non-incretin GPCR target for cardiometabolic diseases Deep Apple is eligible to receive up to $812 ...

According to , Nike plans to unveil Clark's signature logo in Holiday 2025. That means fans will get their first official look at Clark's Nike logo in November or December of this year.

SAN DIEGO--(BUSINESS WIRE)--Candid Therapeutics, Inc. (“Candid”), a clinical-stage biotechnology company redefining the treatment of autoimmune and inflammatory diseases through novel T-cell ...

Leap Therapeutics, Inc. (Nasdaq:LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today reported updated results from Part B of the DeFianCe study ...

Reaction went viral when the team released in March its Baysox Oyster Catchers alternate logo that some fans said resembled intimate body parts. Needless to say, the team is moving on, but not ...

CAMBRIDGE, Mass., June 10, 2025 (GLOBE NEWSWIRE) -- Ernexa Therapeutics (Nasdaq: ERNA), developing innovative cell therapies for the treatment of advanced cancer and autoimmune disease, today ...

The FDA provides a update for Unicycive's NDA for oxylanthanum carbonate to treat hyperphosphatemia in patients with chronic kidney disease. The FDA identified deficiencies in cGMP compliance at a ...

Logos Faith Development, a real estate firm which develops affordable housing projects on underutilized church land, secured an $11 million investment comprised of a capital infusion and a ...

During Wednesday night’s "NBA Countdown" on ABC, NBA commissioner Adam Silver responded to criticism of the digitally inserted images of the Larry O’Brien Trophy shown on the court during the ...

Capable of reversing cellular aging across multiple cell types, without inducing dangerous pluripotency pathways seen in other approaches, SB000 is well positioned as a target for safer, next ...

That startup, Boston-based Antares Therapeutics, launched Tuesday. Scorpion was founded in 2020 by serial biotech entrepreneur Gary Glick.